Found: 11
Select item for more details and to access through your institution.
Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 2, p. 175, doi. 10.3390/pharmaceutics13020175
- By:
- Publication type:
- Article
Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
- Published in:
- Biopharmaceutics & Drug Disposition, 2015, v. 36, n. 4, p. 258, doi. 10.1002/bdd.1933
- By:
- Publication type:
- Article
In vitro metabolism of an estrogen-related receptor γ modulator, GSK5182, by human liver microsomes and recombinant cytochrome P450s.
- Published in:
- Biopharmaceutics & Drug Disposition, 2015, v. 36, n. 3, p. 163, doi. 10.1002/bdd.1929
- By:
- Publication type:
- Article
In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes.
- Published in:
- Biopharmaceutics & Drug Disposition, 2013, v. 34, n. 4, p. 195, doi. 10.1002/bdd.1837
- By:
- Publication type:
- Article
Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer.
- Published in:
- Archives of Pharmacal Research, 2015, v. 38, n. 5, p. 725, doi. 10.1007/s12272-014-0443-0
- By:
- Publication type:
- Article
Screening of six UGT enzyme activities in human liver microsomes using liquid chromatography/triple quadrupole mass spectrometry.
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2014, v. 28, n. 22, p. 2405, doi. 10.1002/rcm.7030
- By:
- Publication type:
- Article
Author Correction: Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndrome.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-020-01540-w
- By:
- Publication type:
- Article
Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 10, p. 1, doi. 10.1002/ctm2.1816
- By:
- Publication type:
- Article
Assessment of pharmacokinetics, bioavailability and protein binding of anacetrapib in rats by a simple high-performance liquid chromatography-tandem mass spectrometry method.
- Published in:
- Biomedical Chromatography, 2017, v. 31, n. 2, p. n/a, doi. 10.1002/bmc.3791
- By:
- Publication type:
- Article
Highly potent and selective PPARd agonist reverses memory deficits in mouse models of Alzheimer's disease.
- Published in:
- Theranostics, 2024, v. 14, n. 16, p. 6088, doi. 10.7150/thno.96707
- By:
- Publication type:
- Article